Evidence map›Paper›PMID 20003619›Full record

ArticleThe international journal of neuropsychopharmacology2010

Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Cedric Mombereau, Tamar L Gur, Jennifer Onksen, Julie A Blendy

Open access · bronzeAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Anxiolytic-Like Effect ofACS omega · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Cedric MombereauDepartment of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Tamar L Gur
Jennifer Onksen
Julie A Blendy
University of Pennsylvania · USCollège de France · FR

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM008076 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 1985 to 2023
$10.8M
TRAINING PROGRAM IN NEUROPSYCHOPHARMACOLOGY-PREDOCTORALT32MH014654 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1985 to 2021
$5.0M
Molecular genetic analysis of drug addictionR01DA011649 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 2000 to 2010
$3.2M
NIDA NIH HHS R01 DA011649NIGMS NIH HHS T32 GM008076NIMH NIH HHS T32 MH014654NIMH NIH HHS T32-MH14654NIMH NIH HHS U01MH0723832
6 · The paper itself

Abstract

Clinically, SSRIs are widely prescribed in the treatment of several anxiety disorders, although very few pre-clinical studies have observed a beneficial effect of this class of drugs in animal models of anxiety. Furthermore, the biphasic pattern observed clinically, an exacerbation of anxiety followed by beneficial effects, is rarely observed in animal studies. In the present study we document this clinical phenomenon in several behavioural paradigms. While a single injection of citalopram induced anxiogenic effects, three administrations of citalopram were sufficient to elicit anxiolytic effects. Congruent with these data, we observed that short-term repeated administration of citalopram was accompanied by increased activation of cAMP response element-binding protein (CREB) in the hippocampus and desensitization of 5-HT1A receptors, two phenomena well associated with chronic rather than acute actions of antidepressants. Moreover, effects of citalopram were abolished in CREBalphaDelta mutant animals in the elevated zero maze (EZM) and tail suspension test (TST), but not in novelty-induced hypophagia (NIH). Further, the desensitization of 5-HT1A receptors elicited by citalopram was not affected by CREB deficiency. The significance of the EZM and TST paradigms in predicting therapeutic efficacy is well known while effects in NIH and 5-HT1A sensitization are less well-established. These data demonstrate that behavioural responses to citalopram are dependent on the frequency of its administration, and that these responses are differentially dependent on CREB function.

Indexed as

AnxietyDepression8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsAntidepressive Agents, Second-GenerationChlordiazepoxideCitalopramCREB-Binding ProteinDisease Models, AnimalDose-Response Relationship, DrugDrug Administration ScheduleGene Expression RegulationHindlimb SuspensionHypothermiaMaze LearningMice8-Hydroxy-2-(di-n-propylamino)tetralinAntidepressive Agents, Second-GenerationChlordiazepoxideCitalopramCREB-Binding Protein

Identifiers

PMID20003619
PMCPMC3646514
OpenAlexW2119839921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.